BioSpace News Archive

Cybin Inc. today announced that an abstract highlighting preclinical data for its deuterated psilocybin analog CYB003 has been selected for a poster presentation at the ‘From Research to Reality’ Global Summit on Psychedelic-Assisted Therapies and Medicines taking place May 27-29, 2022.

9 Meters Biopharma, Inc. announced today that John Temperato, President & Chief Executive Officer of 9 Meters, will present at the LifeSci Partners Immunology & Inflammation Symposium on May 10, 2022, and the H.C. Wainwright Global Investment Conference to be held on May 23-26, 2022.

Treace Medical Concepts, Inc. (“Treace”) (Nasdaq: TMCI), today announced the publication of a peer-reviewed manuscript that details an interim dataset of its ALIGN3D™ multicenter, prospective clinical study in the Journal of Foot & Ankle Surgery.

Today, Swedish biopharmaceutical company TikoMed AB and IQVIA announce a key strategic collaboration with the aim to accelerate the development of TikoMed’s lead drug platform candidate ILB®, a broad-spectrum small molecule drug candidate with curative potential in a wide range of diseases driven by acute and chronic inflammation.

Aulos Bioscience today announced it has dosed the first patient in a Phase 1/2 clinical trial of AU-007 for the treatment of solid tumors.

Alzamend Neuro, Inc. today announced that the first patient with mild to moderate Alzheimer’s disease (“Alzheimer’s”) has been dosed in a 12-month Phase IIA multiple ascending dose (“MAD”) study for dementia related to Alzheimer’s.

Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM) today reported financial results for the first quarter ended March 31, 2022 and provided a business update.

BiomX Inc. today announced that the Company will host a conference call and a live audio webcast on Wednesday, May 11, 2022, at 8:00 a.m. EDT, to report first quarter 2022 financial results and provide business updates.

Accelus, a medical technology company focused on accelerating the adoption of minimally invasive surgery as the standard of care in spine, announced the alpha launch and first procedures performed utilizing its TiHawk7™ expandable interbody cage.

ABVC BioPharma, Inc. announced that Vitargus®, its gel-like substance that helps the eye maintain a round shape and keeps the retina in place during and after retinal re-attachment surgery, will be manufactured through a new aseptic process that enhances the stability, consistency and efficacy of the final product, while significantly reducing manufacturing time.